BiotechTube
Home/Syngle Therapeutics/Dr. Bas Blits
DB

Dr. Bas Blits

Head of R&D / CSO (implied)

Syngle Therapeutics

Therapeutic Areas

Parkinson's DiseaseSynucleinopathies

Syngle Therapeutics Pipeline

DrugIndicationPhase
26F1 AAV Gene TherapyParkinson's DiseasePreclinical

Leadership Team at Syngle Therapeutics

GS
Guus Scheefhals
Chief Executive Officer
VV
Victor van Koolwijk
Chief Financial Officer
View full Syngle Therapeutics profile